Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
Zacks' 7 Best Stocks
for May, 2013
FREE Report for Zacks.com
Visitors Only
Visitors Only
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
- Latest News
- Most Popular
- This Week's Aggressive Growth Stocks
- RTI: What's Moving Treasury Yields Higher?
- Time for Preferred Stock ETFs?
- MedTech Industry Stock Update - May 2013
- RTI: When Do You Sell?
- "Cliffs Notes" on Our Federal Government
- Spotlight on Market and Fed Exit Plan
- Roundtable Top Picks of the Week
- Top-Rated Zacks Rank Sectors
- AWS 5/15: Econ Data - U.S. & Euro - to Play a Role
- PFP 5/15: Why Hit New Highs on Tuesday?
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 05/15/2013
| Company Name | Symbol | %Change |
|---|---|---|
| A M R CP | AAMRQ | 10.54% |
| P L C SYSTEM | PLCSF | 9.19% |
| HUTCHINSON T | HTCH | 6.31% |
| USANA HEALTH | USNA | 6.20% |
| KRATOS DEFEN | KTOS | 5.65% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Berkshire Hathaway announced today that it was buying Lubrizol (LZ) in an all cash deal valued at $9 billion.
The offer is for $135 a share, an all-time high for the stock and a 28% premium on Friday's close of $105.44.
Lubrizol shareholders will get the cash, NOT shares of Berkshire Hathaway. The deal is expected to close in the third quarter of 2011. As has occurred with Buffett's previous deals, current management will stay on to run the company.
Fundamentals Are Solid
It's not surprising that Buffett swooped in on Lubrizol. Valuations have always been good. Shares are currently trading at just 9x forward earnings.
Lubrizol has a stellar return on equity (ROE) of 32.2%, well above the S&P 500 at 23.5% and its peers at just 14.1%.
Earnings growth has slowed now that the global recovery is further along in the cycle, but Lubrizol is still expected to grow earnings at 7.8% in 2011 and 9% in 2012.
You can see the steady growing of the earnings over the last few years, along with the share price, in the 5 year price and consensus chart.
Lubrizol's Been a Great Holding
We've liked Lubrizol for several years. It has been in the Focus List several times, most recently added on August 12, 2010 at the price of $91.53.
With the offer, we have a 46% gain in the shares.
Lubrizol is currently a Zacks #3 Rank (hold) stock.
Tracey Ryniec is the Value Stock Strategist for Zacks.com. She is also the Editor in charge of the market-beating Zacks Value Trader service. You can follow her at twitter.com/traceyryniec.